Search Within

Peter Besmer

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (2)
Groups
  1. Department of Pathology and Laboratory Medicine (11)
  2. Developmental Biology Program Faculty (11)
  3. GSK Faculty (11)
  4. Molecular Pharmacology and Chemistry Program Faculty (11)
  5. Sloan Kettering Institute Faculty (11)
  6. Tow Center for Developmental Oncology (TCDO) (11)

More Groups

People
  1. Cristina Antonescu (11)
  2. Robert Maki (9)
  3. Ronald DeMatteo (8)
  4. Murray Brennan (7)
  5. Samuel Singer (5)
  6. Tianhua Guo (5)

More People

Years
  1. 2010 (1)
  2. 2009 (1)
  3. 2008 (1)
  4. 2007 (3)
  5. 2005 (1)
  6. 2004 (1)

More Years

Publications
  1. Clinical Cancer Research (6)
  2. Cancer (1)
  3. International Journal of Cancer (1)
  4. Laboratory Investigation (1)
  5. Modern Pathology (1)
  6. Molecular Cancer Research (1)
Publishers
  1. American Association for Cancer Research (7)
  2. John Wiley & Sons (1)
  3. Nature Publishing Group (1)
  4. Nature Research (1)
  5. Wiley Blackwell (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib
    Journal Article

    Rossi, F.; Yozgat, Y.; de Stanchina, E.; Veach, D.; Clarkson, B.; Manova, K.; Giancotti, F. G.; Antonescu, C. R.; Besmer, P.
    Molecular Cancer Research (2010)

    Fulltext@MSK | Save
  • Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KIT(AY502-3ins) mutation: An in vitro mutagenesis screen for drug resistance
    Journal Article

    Guo, T.; Hajdu, M.; Agaram, N. P.; Shinoda, H.; Veach, D.; Clarkson, B. D; Maki, R. G.; Singer, S.; DeMatteo, R. P.; Besmer, P.; more...
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)
    Journal Article

    DeMatteo, R. P.; Gold, J. S.; Sarran, L.; Gonen, M.; Liau, K. H.; Maki, R. G.; Singer, S.; Besmer, P.; Brennan, M. F.; Antonescu, C. R.
    Cancer (2008)

    Fulltext@MSK | Save
  • Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor
    Journal Article

    Guo, T.; Agaram, N. P.; Wong, G. C.; Hom, G.; D'adamo, D.; Maki, R. G.; Schwartz, G. K.; Veach, D.; Clarkson, B. D; Singer, S.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition
    Journal Article

    Antonescu, C. R.; Busam, K. J.; Francone, T. D.; Wong, G. C.; Guo, T.; Agaram, N. P.; Besmer, P.; Jungbluth, A.; Gimbel, M.; Chen, C. T.; more...
    International Journal of Cancer (2007)

    Fulltext@MSK | Save
  • Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors
    Journal Article

    Agaram, N. P.; Besmer, P.; Wong, G. C.; Guo, T.; Socci, N. D.; Maki, R. G.; Desantis, D.; Brennan, M. F.; Singer, S.; DeMatteo, R. P.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation
    Journal Article

    Antonescu, C. R.; Besmer, P.; Guo, T.; Arkun, K.; Hom, G.; Korytowsky, B.; Leversha, M. A.; Jeffrey, P. D.; Desantis, D.; Singer, S.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia
    Journal Article

    Robson, M. E.; Glogowski, E.; Sommer, G.; Antonescu, C. R.; Nafa, K.; Maki, R. G.; Ellis, N.; Besmer, P.; Brennan, M.; Offit, K.
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save
  • Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors
    Journal Article

    Antonescu, C. R.; Sommer, G.; Sarran, L.; Tschernyavsky, S. J.; Riedel, E.; Woodruff, J. M.; Robson, M.; Maki, R.; Brennan, M. F.; Ladanyi, M.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Association of KIT exon 9 mutations with non-gastric primary site and size, and lack of prognostic impact of KIT exon 11 mutations. A clinicopathologic and molecular study of 84 gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Antonescu, C. R.; Tschernyavsky, S. J.; Sommers, G.; Riedel, E.; Woodruff, J. M.; Besmer, P.; Maki, R.; Brennan, M. F.; DeMatteo, R.; Ladanyi, M.
    Modern Pathology (2002)

    Fulltext@MSK | Save